Kossel Medtech Awarded Third Prize of 2024 Jiangsu Provincial Science and Technology Progress Award for Innovative Umbrella-Structured Long-Acting Vena Cava Filter
Kossel
Vascular Interventional Device Manufacturer and R&D Developer
Recently, the Jiangsu Provincial Department of Science and Technology announced the list of winners for the 2024 Jiangsu Provincial Science and Technology Awards, including Medpark.Kossel Medtech (Suzhou) Co., Ltd(hereinafter referred to as "Kossel") "Development and Industrialization of Innovative Umbrella-shaped Long-acting Vena Cava Filter Based on Minimally Invasive Intervention Technology" project has wonThird Prize. This project was jointly completed by Kossel, Nanjing University, and Kossel's subsidiary Haiwang Medical Technology (Suzhou) Co., Ltd., marking another significant achievement in industry-academia-research cooperation promoted by Medpark enterprises.
Jiangsu Provincial Science and Technology AwardIt is the highest award in the scientific and technological field of the entire province. This award closely serves major strategies and core needs, focusing on rewarding scientific and technological projects that have achieved significant economic or social benefits in areas such as technological invention, technological development, major engineering construction, promotion and transformation of scientific and technological achievements, high-tech industrialization, and social public welfare. The evaluation is strict, the competition is intense, and the award holds high prestige.
Kossel was founded in 2013 and is located inJiangsu Medical Device Technology ParkLocated in Longshan Science and Innovation Park, Kossel Medtech (Suzhou) Co., Ltd. is a platform enterprise in the field of泛血管介入器械. The company has implemented a global layout around four major business segments: peripheral intervention, coronary intervention, electrophysiology, and medical polymer materials. It has established a comprehensive technology platform and a research and development team of nearly a hundred people, owns hundreds of domestic and international invention patents, holds more than 80 medical device registration certificates in China and abroad, and has achieved a leap from Chinese production substitution to independent innovation.
The integration of industry, academia, and research, following the path of technological innovation, is a key factor for Kossel's sustained rapid growth. The umbrella-shaped long-term vena cava filter project was the first core product the company focused on after its establishment, involving the deep interdisciplinary integration of materials science, chemistry, mechanics, clinical medicine, and more.Achieve multiple technological innovations。
The project was launched in 2014, with the first-generation product entering the market in 2021 to fill the gap in China, and the second-generation vena cava filter is set to be released in 2025 after an upgrade.After a long journey from original innovation to technological breakthrough, from achievement transformation to large-scale application, the vena cava filter has gained deep recognition and application in over 2,000 medical centers across China. With its unique umbrella design, excellent thrombus interception capability, and high stability, it has successfully protected the lives and health of tens of thousands of patients, becoming a representative Chinese product in the field of VTE prevention and treatment.
Kossel's receipt of this award is not only a certification of the company's innovative achievements but also a testament to the continuous improvement of the innovation ecosystem and the cultivation of high-growth enterprises in Jiangsu Medical Device Technology Park.Next, Medpark will continue to strengthen the growth of innovative entities, vigorously cultivate technology-leading enterprises, support leading enterprises in taking the lead in forming innovation consortia, and accelerate the construction of an innovation ecosystem dominated by enterprises with deep integration of industry, academia, and research.
